AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2004
May 4, 2004
29777_dirs_2004-05-04_37d5e273-2684-4008-95cf-da81982dddf4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-04-30
Reporting Person: BEGLEY CHRISTOPHER B (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-04-30 | Common Shares | F | 3506 | $41.465 | Disposed | 240618 | Direct |
| 2004-04-30 | Common Shares | F | 10543 | $41.465 | Disposed | 230075 | Direct |
| 2004-04-30 | Common Shares | F | 7591 | $41.465 | Disposed | 222484 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 14009 | Indirect |
Footnotes
F1: These are holdings as of Mr. Begley's last day as Abbott Laboratories' Senior Vice President, Hospital Products, as a result of the April 30, 2004 spin-off of Hospira, Inc. from Abbott Laboratories. Mr. Begley is Chief Executive Officer of Hospira, Inc.
F2: Balance in the Abbott Laboratories Stock Retirement Trust as of April 30, 2004.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25